Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease.
Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease.
复制标题
抑制增食欲素/下丘脑神经元能改善A53T帕金森病小鼠模型中增加的体力活动和能量消耗。
DOI:
10.3390/ijms22020795
复制
发表时间:
2021-01-14
影响因子:
5.6
通讯作者:
Kotz CM
中科院分区:
文献类型:
--
作者:
Stanojlovic M;Pallais JP;Kotz CM
Aside from the classical motor symptoms, Parkinson’s disease also has various non-classical symptoms. Interestingly, orexin neurons, involved in the regulation of exploratory locomotion, spontaneous physical activity, and energy expenditure, are affected in Parkinson’s. In this study, we hypothesized that Parkinson’s-disease-associated pathology affects orexin neurons and therefore impairs functions they regulate. To test this, we used a transgenic animal model of Parkinson’s, the A53T mouse. We measured body composition, exploratory locomotion, spontaneous physical activity, and energy expenditure. Further, we assessed alpha-synuclein accumulation, inflammation, and astrogliosis. Finally, we hypothesized that chemogenetic inhibition of orexin neurons would ameliorate observed impairments in the A53T mice. We showed that aging in A53T mice was accompanied by reductions in fat mass and increases in exploratory locomotion, spontaneous physical activity, and energy expenditure. We detected the presence of alpha-synuclein accumulations in orexin neurons, increased astrogliosis, and microglial activation. Moreover, loss of inhibitory pre-synaptic terminals and a reduced number of orexin cells were observed in A53T mice. As hypothesized, this chemogenetic intervention mitigated the behavioral disturbances induced by Parkinson’s disease pathology. This study implicates the involvement of orexin in early Parkinson’s-disease-associated impairment of hypothalamic-regulated physiological functions and highlights the importance of orexin neurons in Parkinson’s disease symptomology.
登录
查看更多内容
影响因子:
12.7
作者:
Bengoa-Vergniory N;Roberts RF;Wade-Martins R;Alegre-Abarrategui J
通讯作者:
Alegre-Abarrategui J
影响因子:
7.1
作者:
Arawaka S;Sato H;Sasaki A;Koyama S;Kato T
通讯作者:
Kato T
影响因子:
5.6
作者:
de Lecea L;Huerta R
通讯作者:
Huerta R
DOI:
10.1038/ijo.2017.92
发表时间:
2017-08
期刊:
International journal of obesity (2005)
影响因子:
--
作者:
Coborn JE;DePorter DP;Mavanji V;Sinton CM;Kotz CM;Billington CJ;Teske JA
通讯作者:
Teske JA
影响因子:
3.8
作者:
Anandhan A;Jacome MS;Lei S;Hernandez-Franco P;Pappa A;Panayiotidis MI;Powers R;Franco R
通讯作者:
Franco R